These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 27849030)
41. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses. Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745 [TBL] [Abstract][Full Text] [Related]
42. Did the H1N1 Vaccine Reduce the Risk of Admission with Influenza and Pneumonia during the Pandemic? Mahmud SM; Bozat-Emre S; Hammond G; Elliott L; Van Caeseele P PLoS One; 2015; 10(11):e0142754. PubMed ID: 26600435 [TBL] [Abstract][Full Text] [Related]
43. Long term effectiveness of adjuvanted influenza A(H1N1)pdm09 vaccine in children. Örtqvist Å; Bennet R; Hamrin J; Rinder MR; Lindblad H; Öhd JN; Eriksson M Vaccine; 2015 May; 33(22):2558-61. PubMed ID: 25869891 [TBL] [Abstract][Full Text] [Related]
44. Severe influenza A(H1N1)pdm09 infection induces thymic atrophy through activating innate CD8(+)CD44(hi) T cells by upregulating IFN-γ. Liu B; Zhang X; Deng W; Liu J; Li H; Wen M; Bao L; Qu J; Liu Y; Li F; An Y; Qin C; Cao B; Wang C Cell Death Dis; 2014 Oct; 5(10):e1440. PubMed ID: 25275588 [TBL] [Abstract][Full Text] [Related]
45. Randomized controlled ferret study to assess the direct impact of 2008-09 trivalent inactivated influenza vaccine on A(H1N1)pdm09 disease risk. Skowronski DM; Hamelin ME; De Serres G; Janjua NZ; Li G; Sabaiduc S; Bouhy X; Couture C; Leung A; Kobasa D; Embury-Hyatt C; de Bruin E; Balshaw R; Lavigne S; Petric M; Koopmans M; Boivin G PLoS One; 2014; 9(1):e86555. PubMed ID: 24475142 [TBL] [Abstract][Full Text] [Related]
46. Co-stimulation With TLR7 Agonist Imiquimod and Inactivated Influenza Virus Particles Promotes Mouse B Cell Activation, Differentiation, and Accelerated Antigen Specific Antibody Production. Li C; To KKW; Zhang AJX; Lee ACY; Zhu H; Mak WWN; Hung IFN; Yuen KY Front Immunol; 2018; 9():2370. PubMed ID: 30369932 [TBL] [Abstract][Full Text] [Related]
47. Cross-reactive T cells are involved in rapid clearance of 2009 pandemic H1N1 influenza virus in nonhuman primates. Weinfurter JT; Brunner K; Capuano SV; Li C; Broman KW; Kawaoka Y; Friedrich TC PLoS Pathog; 2011 Nov; 7(11):e1002381. PubMed ID: 22102819 [TBL] [Abstract][Full Text] [Related]
48. Vaccine based on antibody-dependent cell-mediated cytotoxicity epitope on the H1N1 influenza virus increases mortality in vaccinated mice. Wang J; Liu M; Ding N; Li Y; Shao J; Zhu M; Xie Z; Sun K Biochem Biophys Res Commun; 2018 Sep; 503(3):1874-1879. PubMed ID: 30064910 [TBL] [Abstract][Full Text] [Related]
51. Autophagy is involved in regulating the immune response of dendritic cells to influenza A (H1N1) pdm09 infection. Zang F; Chen Y; Lin Z; Cai Z; Yu L; Xu F; Wang J; Zhu W; Lu H Immunology; 2016 May; 148(1):56-69. PubMed ID: 26800655 [TBL] [Abstract][Full Text] [Related]
53. Synergy between the classical and alternative pathways of complement is essential for conferring effective protection against the pandemic influenza A(H1N1) 2009 virus infection. Rattan A; Pawar SD; Nawadkar R; Kulkarni N; Lal G; Mullick J; Sahu A PLoS Pathog; 2017 Mar; 13(3):e1006248. PubMed ID: 28301559 [TBL] [Abstract][Full Text] [Related]
54. Sterilizing immunity to influenza virus infection requires local antigen-specific T cell response in the lungs. Dutta A; Huang CT; Lin CY; Chen TC; Lin YC; Chang CS; He YC Sci Rep; 2016 Sep; 6():32973. PubMed ID: 27596047 [TBL] [Abstract][Full Text] [Related]
55. Large scale genome analysis shows that the epitopes for broadly cross-reactive antibodies are predominant in the pandemic 2009 influenza virus A H1N1 strain. Lara-Ramírez EE; Segura-Cabrera A; Salazar MI; Rodríguez-Pérez MA; Guo X Viruses; 2013 Nov; 5(11):2796-802. PubMed ID: 24257096 [TBL] [Abstract][Full Text] [Related]
56. Immunity to seasonal and pandemic influenza A viruses. Valkenburg SA; Rutigliano JA; Ellebedy AH; Doherty PC; Thomas PG; Kedzierska K Microbes Infect; 2011 May; 13(5):489-501. PubMed ID: 21295153 [TBL] [Abstract][Full Text] [Related]
57. PD-L1 expression induced by the 2009 pandemic influenza A(H1N1) virus impairs the human T cell response. Valero-Pacheco N; Arriaga-Pizano L; Ferat-Osorio E; Mora-Velandia LM; Pastelin-Palacios R; Villasís-Keever MÁ; Alpuche-Aranda C; Sánchez-Torres LE; Isibasi A; Bonifaz L; López-Macías C Clin Dev Immunol; 2013; 2013():989673. PubMed ID: 24187568 [TBL] [Abstract][Full Text] [Related]
58. Enhanced CD103 Expression and Reduced Frequencies of Virus-Specific CD8 Surman SL; Jones BG; Woodland DL; Hurwitz JL Viral Immunol; 2017 Dec; 30(10):737-743. PubMed ID: 29130830 [TBL] [Abstract][Full Text] [Related]
59. Dysregulated T-Helper Type 1 (Th1):Th2 Cytokine Profile and Poor Immune Response in Pregnant Ferrets Infected With 2009 Pandemic Influenza A(H1N1) Virus. Yoon SW; Wong SS; Zhu H; Chen R; Li L; Zhang Y; Guan Y; Webby RJ J Infect Dis; 2018 Jan; 217(3):438-442. PubMed ID: 28973317 [TBL] [Abstract][Full Text] [Related]
60. Pulmonary inflammation and cytokine dynamics of bronchoalveolar lavage fluid from a mouse model of bronchial asthma during A(H1N1)pdm09 influenza infection. Fujimoto Y; Hasegawa S; Matsushige T; Wakiguchi H; Nakamura T; Hasegawa H; Nakajima N; Ainai A; Oga A; Itoh H; Shirabe K; Toda S; Atsuta R; Morishima T; Ohga S Sci Rep; 2017 Aug; 7(1):9128. PubMed ID: 28831046 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]